New technological developments portend radical changes in the way the pharmaceutical industry will conduct clinical trials for new drug development in future – in fact, the rapid pace of techno-change predicts revolution in the wide arena of human health care.
But is it really a ‘revolution’ that looms on the horizon? Or is ‘evolution’ the better – and more welcome – description of the road that lies ahead?
David Goldston, Managing Director of Veracity Logic, shares his thoughts and predictions in the Spring edition of International Clinical Trials (May 2018, pages 14-16. © Samedan Ltd.).
Click here to browse the issue, and use the button below to download the article.
Share this Post